YANKCOM Partnership’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
YANKCOM Partnership's AMGN Position: Q3 2026 in Review
YANKCOM Partnership reduced its Amgen (AMGN) stake by 2.4% in Q3 2026, selling an estimated $12.8K and leaving 1,309 shares worth $552K. The position accounts for 0.19% of the portfolio, ranked #93.
YANKCOM Partnership first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- YANKCOM Partnership held 1,309 shares of Amgen worth $552K as of Q3 2026.
- YANKCOM Partnership sold 32 Amgen shares in Q3 2026, an estimated $12.8K.
- Amgen made up 0.19% of YANKCOM Partnership's portfolio in Q3 2026, its #93 holding.
- YANKCOM Partnership first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
- 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.